×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agendas
Session 0803 Breakthrough Therapies in Diabetes Diseases
Session Chair(s)
Yan Gong
Senior Global Clinical Program Lead, Corporate Division of Medicine
Boehringer-Ingelheim, Germany, China
Huaqiong SHEN, MD, PhD
Chief Medical Officer
Jiangsu Hengrui Medicine Co., Ltd., China
Speaker(s)
Diabetes Treatment - Insulin and GLP-1
Kezhou Zhang
Novo Nordisk (China) Pharmaceuticals Co. Ltd., China
Vice President, Clinical & Medical & Regulatory
Recent advancement of drug development in diabetes - synthetic chemical entity
ShuHua SHANG
sanofi, China
Clinical Research Director
Yan Gong
Boehringer-Ingelheim, Germany, China
Senior Global Clinical Program Lead, Corporate Division of Medicine
Status Quo, Challenges and Opportunities for Domestic Companies in Diabetes Therapies
Eric Hua
Gan & Lee Pharmaceuticals, China
Overseas Clinical Project Manager, Clinical Operations
Pipeline in Diabetes – From the Industrial Perspective (EN&CN)
Chengyu Guan
Jiangsu Hengrui Medicine Co., Ltd, China, China
Medical Director
Have an account?